Search Results - "Bulzis, G."

Nasal disorders and cardiovascular damage: flow-mediated dilation and intima-media thickness as risk parameters by Gelardi, M., Giancaspro, R., Iannuzzi, L., Taliente, S., Piccininni, K., Quaranta, N., Bulzis, G., Sasso, N., Carbonara, R., Ciccone, M.M., Cassano, M.

Get full text

SGLT2i IN THE REAL WORLD: DATA FROM THE PONTE (bridge) HF PROJECT (PDTA FOR INTEGRATED TERRITORY HOSPITAL FOLLOW-UP OF PATIENTS WITH HEART FAILURE) by De Gennaro, L, Grande, D, Bulzis, G, Carbonara, R, Cataneo, L, Correale, M, De Masi De Luca, G, Di Stolfo, G, Ferraretti, A, Galgano, G, Gioia, M, Leone, M, Malerba, L, Marazia, S, Minielli, V, Petruzzi, P, Potenza, A, Lamacchia, O, Iacoviello, M, Caldarola, P

“…Abstract Background Over the last few years, treatment with sodium glucose cotransporter 2 inhibitors (SGLT2i) dapaglifozin and empaglifozin was shown to…”
Get full text

P2632Gestational hypertension: endothelial dysfunction as a marker of pre-eclampsia by Ciccone, M.M., Carbonara, R., Giardinelli, F., Zito, A., Ricci, G., Dentamaro, I., Bulzis, G., Catalano, M., Panettieri, I., Loverro, G., Vulpis, V.

Get full text

P71 SGLT2I IN THE REAL WORLD: DATA FROM THE PONTE (BRIDGE) HF PROJECT (PDTA FOR INTEGRATED TERRITORY HOSPITAL FOLLOW–UP OF PATIENTS WITH HEART FAILURE) by De Gennaro, L, Iacoviello, M, Grande, D, Bulzis, G, Cataneo, L, Citarelli, G, Correale, M, De Masi, G, Donadeo, V, Di Stolfo, G, Ferraretti, A, Galgano, G, Gioia, I, Leone, M, Malerba, L, Marazia, S, Minielli, V, Petruzzi, P, Potenza, A, Rizzo, C, Ruggiero, M, Brunetti, N, Caldarola, P

“…Abstract Background The DAPA–HF and the EMPEROR reduced trials showed that sodium–glucose cotransporter type 2 inhibitors (SGLT2i) dapagliflozin and…”
Get full text